Bortezomib-Induced Skin Lesion

Publisher： Karger

E-ISSN： 1421-9662|116|3|226-227

ISSN： 0001-5792

Source： Acta Haematologica, Vol.116, Iss.3, 2006-10, pp. : 226-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bortezomib-Induced Rhabdomyolysis in Multiple Myeloma

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

Olanzapine-Induced Reversible Pellagroid Skin Lesion

By  

Current Drug Safety, Vol. 10, Iss. 3, 2015-01 ,pp. : 251-253

Bentham Science Publishers

Access to resources Recommend Favorite

Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 134, Iss. 1, 2015-04 ,pp. : 25-31

Karger

Access to resources Recommend Favorite

A pigmented skin lesion on the back

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 12, 2015-12 ,pp. : e509-e511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improvement of Zoledronic Acid-Induced Jaw Osteonecrosis with Bortezomib

By  

Acta Haematologica, Vol. 118, Iss. 4, 2007-11 ,pp. : 203-204

Karger

Access to resources Recommend Favorite